Trials / Terminated
TerminatedNCT03781375
Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis
A Phase III Double Blind Randomized Study Comparing Etanercept (Enbrel) Combined With Methotrexate vs Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Amgen · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study was to determine the efficacy of etanercept plus methotrexate vs methotrexate alone in pediatric patients with active polyarticular course juvenile rheumatoid arthritis (JRA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etanercept | Administered by subcutaneous injection twice a week |
| DRUG | Placebo to Etanerceot | Administered by subcutaneous injection twice a week |
| DRUG | Methotrexate | Administered orally or subcutaneously once a week at the same dose as prior to study entry |
Timeline
- Start date
- 2000-08-24
- Primary completion
- 2002-06-20
- Completion
- 2002-06-24
- First posted
- 2018-12-19
- Last updated
- 2019-08-02
- Results posted
- 2019-08-02
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03781375. Inclusion in this directory is not an endorsement.